Therefore, it seems likely that post-transcriptional upregulation of both BACE1 and its substrate APP may work cooperatively, leading to significant acceleration of β-amyloidogenesis in brains of insulin-deficient diabetic AD mice. Here, APP is linked to Alzheimer disease.